236 related articles for article (PubMed ID: 17088406)
1. Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent.
MacRae VE; Burdon T; Ahmed SF; Farquharson C
J Endocrinol; 2006 Nov; 191(2):369-77. PubMed ID: 17088406
[TBL] [Abstract][Full Text] [Related]
2. Paracrine and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line.
Locker M; Kellermann O; Boucquey M; Khun H; Huerre M; Poliard A
J Bone Miner Res; 2004 Jan; 19(1):100-10. PubMed ID: 14753742
[TBL] [Abstract][Full Text] [Related]
3. IGF-I signalling in bone growth: inhibitory actions of dexamethasone and IL-1beta.
Macrae VE; Ahmed SF; Mushtaq T; Farquharson C
Growth Horm IGF Res; 2007 Oct; 17(5):435-9. PubMed ID: 17590365
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IGF-I-related intracellular signaling pathways by proinflammatory cytokines in growth plate chondrocytes.
Choukair D; Hügel U; Sander A; Uhlmann L; Tönshoff B
Pediatr Res; 2014 Sep; 76(3):245-51. PubMed ID: 24941214
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells.
Arboleda G; Huang TJ; Waters C; Verkhratsky A; Fernyhough P; Gibson RM
Eur J Neurosci; 2007 May; 25(10):3030-8. PubMed ID: 17561816
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I and fibroblast growth factor, but not growth hormone, affect growth plate chondrocyte proliferation.
Hutchison MR; Bassett MH; White PC
Endocrinology; 2007 Jul; 148(7):3122-30. PubMed ID: 17395707
[TBL] [Abstract][Full Text] [Related]
7. Insulin-Like Growth Factor-Independent Effects of Growth Hormone on Growth Plate Chondrogenesis and Longitudinal Bone Growth.
Wu S; Yang W; De Luca F
Endocrinology; 2015 Jul; 156(7):2541-51. PubMed ID: 25910049
[TBL] [Abstract][Full Text] [Related]
8. Igf-I extends the chondrogenic potential of human articular chondrocytes in vitro: molecular association between Sox9 and Erk1/2.
Shakibaei M; Seifarth C; John T; Rahmanzadeh M; Mobasheri A
Biochem Pharmacol; 2006 Nov; 72(11):1382-95. PubMed ID: 17010943
[TBL] [Abstract][Full Text] [Related]
9. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts.
Strle K; Broussard SR; McCusker RH; Shen WH; LeCleir JM; Johnson RW; Freund GG; Dantzer R; Kelley KW
Endocrinology; 2006 Sep; 147(9):4363-73. PubMed ID: 16777978
[TBL] [Abstract][Full Text] [Related]
10. The role of insulin in chondrogenesis.
Phornphutkul C; Wu KY; Gruppuso PA
Mol Cell Endocrinol; 2006 Apr; 249(1-2):107-15. PubMed ID: 16530934
[TBL] [Abstract][Full Text] [Related]
11. [Stanozolol activates the cross-talk of estrogen receptor alpha-insulin-like growth factor-1 receptor-extracellular-signal regulated kinase 1/2 in the growth plate chondrocytes of estrogen-inhibited adolescent rats in vitro].
Zhu SY; Li YH; Ma HM; Pan SN; Chen HS; DU ML
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):774-8. PubMed ID: 20021813
[TBL] [Abstract][Full Text] [Related]
12. Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis.
Stewart CE; Newcomb PV; Savage PB; Dickens M; Tavare J; Holly JM
Growth Horm IGF Res; 1999 Apr; 9(2):131-42. PubMed ID: 10373346
[TBL] [Abstract][Full Text] [Related]
13. Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation.
Gaur T; Rich L; Lengner CJ; Hussain S; Trevant B; Ayers D; Stein JL; Bodine PV; Komm BS; Stein GS; Lian JB
J Cell Physiol; 2006 Jul; 208(1):87-96. PubMed ID: 16575902
[TBL] [Abstract][Full Text] [Related]
14. Defined carboxy-terminal fragments of insulin-like growth factor (IGF) binding protein-2 exert similar mitogenic activity on cultured rat growth plate chondrocytes as IGF-I.
Kiepe D; Van Der Pas A; Ciarmatori S; Ständker L; Schütt B; Hoeflich A; Hügel U; Oh J; Tönshoff B
Endocrinology; 2008 Oct; 149(10):4901-11. PubMed ID: 18556354
[TBL] [Abstract][Full Text] [Related]
15. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
[TBL] [Abstract][Full Text] [Related]
16. Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton of SOCS2 deficient mice.
Macrae VE; Horvat S; Pells SC; Dale H; Collinson RS; Pitsillides AA; Ahmed SF; Farquharson C
J Cell Physiol; 2009 Feb; 218(2):276-84. PubMed ID: 18803233
[TBL] [Abstract][Full Text] [Related]
17. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling.
Longobardi L; O'Rear L; Aakula S; Johnstone B; Shimer K; Chytil A; Horton WA; Moses HL; Spagnoli A
J Bone Miner Res; 2006 Apr; 21(4):626-36. PubMed ID: 16598383
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.
Strle K; Broussard SR; McCusker RH; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
Endocrinology; 2004 Oct; 145(10):4592-602. PubMed ID: 15256490
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of beta-catenin signaling.
Wang L; Shao YY; Ballock RT
J Bone Miner Res; 2010 May; 25(5):1138-46. PubMed ID: 20200966
[TBL] [Abstract][Full Text] [Related]
20. Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor.
Kolettas E; Muir HI; Barrett JC; Hardingham TE
Rheumatology (Oxford); 2001 Oct; 40(10):1146-56. PubMed ID: 11600745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
